ABSI NASDAQ
Absci Corporation
1W: +10.7%
1M: -3.0%
3M: +32.5%
YTD: +161.8%
1Y: +120.8%
3Y: +605.2%
5Y: -13.4%
$10.57
+1.12 (+11.85%)
After Hours: $10.59 (+0.02, +0.19%)
Weekly Expected Move ±15.2%
$6
$8
$9
$11
$12
Credit Risk of going bust: lower than 61% of companies Debt: 0.2% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.00 (down more than 99.9%), Absci Corporation would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $1.62B.
Distance to default 6.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 100.4%; Altman Z'' 4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
If the stock fell to about $0.00 (down more than 99.9%), Absci Corporation would be worth roughly what it owes.
Total debt $3.7M against a stock market value of $1.62B.
Distance to default 6.31 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $1.8M (short-term plus half of long-term), stock volatility 100.4%; Altman Z'' 4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.3M
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.6B
52W Range2.24-12.06
Volume3,360,259
Avg Volume4,439,524
Beta2.28
Dividend—
Analyst Ratings
Company Info
CEOSean McClain
Employees140
SectorHealthcare
IndustryBiotechnology
IPO Date2021-07-22
Websiteabsci.com
18105 SE Mill Plain Boulevard
Vancouver, WA 98683
US
Vancouver, WA 98683
US
360 949 1041
About Absci Corporation
Absci Corporation operates as a biopharmaceutical company primarily focused on discovering novel drug targets and developing new therapeutic compounds. Leveraging its distinctive integrated drug creation platform, the firm generates potential biologic medicines and essential cell lines for manufacturing, which it provides to its collaborators, predominantly within the United States. This advanced platform is instrumental in facilitating the development of biologics by meticulously integrating the traditionally separate stages of drug discovery and cell line engineering into one streamlined process. Absci Corporation was founded in 2011 and is based in Vancouver, Washington.
Latest News
Absci to Participate in Upcoming Investor Conferences
Absci to Participate in Upcoming Investor Conferences - Yahoo Finance
Absci (NASDAQ:ABSI) Stock Crosses Above 50-Day Moving Average - Here's Why - MarketBeat
How Investors Are Reacting To Absci (ABSI) Early Hair Loss Trial Data - Simply Wall Street
Is Absci (ABSI) Undervalued As Positive ABS 201 Phase 1 Data Lifts Optimism?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Bedrick Todd | F-InKind | 22,325 | $10.16 | 2026-10-12 |
| Jonasson Zachariah | F-InKind | 387 | $10.16 | 2026-10-12 |
| McClain Sean | F-InKind | 23,293 | $10.16 | 2026-10-12 |
| Jonasson Zachariah | F-InKind | 8,320 | $8.71 | 2026-08-31 |
| Somaratne Ransi Muda | A-Award | 383,000 | $7.93 | 2026-08-03 |